Atossa Therapeutics, Inc (ATOS) insider trading

Every open-market stock purchase and sale by Atossa Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Steven C Quay (CEO), $9.9K, 16 months ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).

Recent ATOS insider trades

DateInsiderTradeValue
May 12, 2026Shu-Chih Chen (Insider)Bought (not open market)—
May 12, 2026Stephen J Galli (Insider)Bought (not open market)—
May 12, 2026Richard I Steinhart (Insider)Bought (not open market)—
May 12, 2026Tessa Cigler (Insider)Bought (not open market)—
May 12, 2026H. Lawrence Remmel (Insider)Bought (not open market)—
May 12, 2026Jonathan Finn (Insider)Bought (not open market)—
Mar 27, 2026Steven C Quay (CEO)Bought (not open market)—
Mar 26, 2026Mark James Daniel (CFO)Bought (not open market)—
Jan 20, 2026Steven C Quay (CEO)Bought (not open market)$573K
Jan 20, 2026Steven C Quay (CEO)Bought (not open market)$573K
Jan 20, 2026Steven C Quay (CEO)Bought (not open market)—
Jan 20, 2026Steven C Quay (CEO)Bought (not open market)—
Oct 14, 2025Mark James Daniel (CFO)Bought (not open market)—

Who's trading ATOS

Get free alerts when an insider at Atossa Therapeutics, Inc files a new trade →